Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytotect for prevention of maternal-fetal transmission of primary cytomegalovirus infection in pregnancy
2008-006560-11Phase 2Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Feb 2009
- Modality
- IgG Antibodies → Naked Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of human cytomegalovirus immune globulin in cytomegalovirus disease (CMV) (2 arms), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Number of HCMV-infected newborns or fetuses. Started Feb 2009; status: completed.
02
Drugs
human cytomegalovirus immune globulin
03
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on 2008-006560-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006560-11.